Annual CFF
$2.20 M
+$469.00 K+27.05%
01 December 2023
Summary:
Bio-Path Holdings annual cash flow from financing activities is currently $2.20 million, with the most recent change of +$469.00 thousand (+27.05%) on 01 December 2023. During the last 3 years, it has fallen by -$17.80 million (-88.99%). BPTH annual CFF is now -92.07% below its all-time high of $27.78 million, reached on 31 December 2019.BPTH Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$16.00 K
-$7.06 M-100.23%
01 September 2024
Summary:
Bio-Path Holdings quarterly cash flow from financing activities is currently -$16.00 thousand, with the most recent change of -$7.06 million (-100.23%) on 01 September 2024. Over the past year, it has dropped by -$530.00 thousand (-103.11%). BPTH quarterly CFF is now -100.08% below its all-time high of $20.28 million, reached on 31 March 2019.BPTH Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$7.72 M
-$1.71 M-18.09%
01 September 2024
Summary:
Bio-Path Holdings TTM cash flow from financing activities is currently $7.72 million, with the most recent change of -$1.71 million (-18.09%) on 01 September 2024. Over the past year, it has increased by +$5.51 million (+250.34%). BPTH TTM CFF is now -72.22% below its all-time high of $27.78 million, reached on 31 December 2019.BPTH TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BPTH Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -103.1% | +250.3% |
| 3 y3 years | -89.0% | -433.3% | -61.4% |
| 5 y5 years | -92.1% | -100.2% | -72.2% |
BPTH Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -89.0% | +27.1% | -100.2% | at low | -61.4% | >+9999.0% |
| 5 y | 5 years | -92.1% | +27.1% | -100.1% | at low | -72.2% | >+9999.0% |
| alltime | all time | -92.1% | +3057.1% | -100.1% | +81.3% | -72.2% | +9675.7% |
Bio-Path Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$16.00 K(-100.2%) | $7.72 M(-18.1%) |
| June 2024 | - | $7.05 M(+3949.4%) | $9.42 M(+296.4%) |
| Mar 2024 | - | $174.00 K(-66.1%) | $2.38 M(+7.9%) |
| Dec 2023 | $2.20 M(+27.0%) | $514.00 K(-69.6%) | $2.20 M(-35.6%) |
| Sept 2023 | - | $1.69 M(>+9900.0%) | $3.42 M(+97.4%) |
| June 2023 | - | $0.00(0.0%) | $1.73 M(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) | $1.73 M(0.0%) |
| Dec 2022 | $1.73 M(-91.3%) | $1.73 M(>+9900.0%) | $1.73 M(<-9900.0%) |
| Sept 2022 | - | $0.00(-100.0%) | -$3000.00(-100.0%) |
| Dec 2021 | $20.01 M(+366.4%) | -$3000.00(-100.2%) | $20.01 M(-17.7%) |
| Sept 2021 | - | $1.40 M(>+9900.0%) | $24.30 M(+6.1%) |
| June 2021 | - | $0.00(-100.0%) | $22.90 M(0.0%) |
| Mar 2021 | - | $18.61 M(+333.9%) | $22.90 M(+433.9%) |
| Dec 2020 | $4.29 M(-84.6%) | $4.29 M(>+9900.0%) | $4.29 M(-41.2%) |
| Sept 2020 | - | $0.00(0.0%) | $7.29 M(-2.3%) |
| June 2020 | - | $0.00(0.0%) | $7.46 M(-0.6%) |
| Mar 2020 | - | $0.00(-100.0%) | $7.50 M(-73.0%) |
| Dec 2019 | $27.78 M(+2254.5%) | $7.29 M(+4213.0%) | $27.78 M(+35.6%) |
| Sept 2019 | - | $169.00 K(+275.6%) | $20.50 M(-4.7%) |
| June 2019 | - | $45.00 K(-99.8%) | $21.50 M(+0.2%) |
| Mar 2019 | - | $20.28 M(>+9900.0%) | $21.46 M(+1718.6%) |
| Dec 2018 | $1.18 M(-76.8%) | $1000.00(-99.9%) | $1.18 M(-75.1%) |
| Sept 2018 | - | $1.18 M(>+9900.0%) | $4.75 M(+34.2%) |
| June 2018 | - | $0.00(0.0%) | $3.54 M(-30.4%) |
| Mar 2018 | - | $0.00(-100.0%) | $5.08 M(0.0%) |
| Dec 2017 | $5.08 M(-43.5%) | $3.57 M(<-9900.0%) | $5.08 M(+235.0%) |
| Sept 2017 | - | -$30.00 K(-101.9%) | $1.52 M(-85.6%) |
| June 2017 | - | $1.55 M(>+9900.0%) | $10.55 M(+17.2%) |
| Dec 2016 | $9.01 M(>+9900.0%) | $0.00(-100.0%) | $9.01 M(0.0%) |
| Sept 2016 | - | $9.01 M(>+9900.0%) | $9.01 M(>+9900.0%) |
| June 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2015 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2015 | - | $0.00(-100.0%) | $434.60 K(-96.9%) |
| Dec 2014 | $14.25 M(+167.3%) | $434.60 K(>+9900.0%) | $14.25 M(+3.7%) |
| Sept 2014 | - | $0.00(0.0%) | $13.74 M(-17.4%) |
| June 2014 | - | $0.00(-100.0%) | $16.63 M(-11.7%) |
| Mar 2014 | - | $13.81 M(<-9900.0%) | $18.84 M(+253.4%) |
| Dec 2013 | $5.33 M | -$72.20 K(-102.5%) | $5.33 M(-11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2013 | - | $2.89 M(+30.6%) | $6.03 M(+56.6%) |
| June 2013 | - | $2.21 M(+623.0%) | $3.85 M(+107.5%) |
| Mar 2013 | - | $305.70 K(-51.3%) | $1.86 M(+16.0%) |
| Dec 2012 | $1.60 M(-21.3%) | $627.10 K(-11.5%) | $1.60 M(+8.6%) |
| Sept 2012 | - | $708.40 K(+229.6%) | $1.47 M(+63.3%) |
| June 2012 | - | $214.90 K(+331.5%) | $902.00 K(-35.5%) |
| Mar 2012 | - | $49.80 K(-90.0%) | $1.40 M(-31.2%) |
| Dec 2011 | $2.03 M(+93.9%) | $500.20 K(+264.8%) | $2.03 M(+8.6%) |
| Sept 2011 | - | $137.10 K(-80.7%) | $1.87 M(-1.6%) |
| June 2011 | - | $711.70 K(+4.0%) | $1.90 M(+24.0%) |
| Mar 2011 | - | $684.60 K(+101.5%) | $1.53 M(+46.3%) |
| Dec 2010 | $1.05 M(+42.2%) | $339.80 K(+104.0%) | $1.05 M(-19.9%) |
| Sept 2010 | - | $166.60 K(-51.6%) | $1.31 M(+15.1%) |
| June 2010 | - | $344.00 K(+73.0%) | $1.14 M(+21.0%) |
| Mar 2010 | - | $198.80 K(-66.9%) | $940.50 K(+27.5%) |
| Dec 2009 | $737.60 K(-46.1%) | $599.90 K(<-9900.0%) | $737.60 K(+521.4%) |
| Sept 2009 | - | -$4900.00(-103.3%) | $118.70 K(+7.2%) |
| June 2009 | - | $146.70 K(-3678.0%) | $110.70 K(-362.3%) |
| Mar 2009 | - | -$4100.00(-78.4%) | -$42.20 K(-103.1%) |
| Dec 2008 | $1.37 M(-1936.6%) | -$19.00 K(+47.3%) | $1.37 M(-7.7%) |
| Sept 2008 | - | -$12.90 K(+108.1%) | $1.48 M(-1.0%) |
| June 2008 | - | -$6200.00(-100.4%) | $1.50 M(+1.0%) |
| Mar 2008 | - | $1.41 M(+1372.8%) | $1.48 M(<-9900.0%) |
| Dec 2007 | - | $95.50 K(+4675.0%) | -$9900.00(-87.7%) |
| Sept 2007 | - | $2000.00(-109.2%) | -$80.60 K(+8.2%) |
| June 2007 | -$74.50 K(-169.3%) | -$21.70 K(-74.7%) | -$74.50 K(+43.3%) |
| Mar 2007 | - | -$85.70 K(-445.6%) | -$52.00 K(-188.7%) |
| Dec 2006 | - | $24.80 K(+206.2%) | $58.60 K(+83.7%) |
| Sept 2006 | - | $8100.00(+912.5%) | $31.90 K(-70.4%) |
| June 2006 | $107.50 K(+122.1%) | $800.00(-96.8%) | $107.60 K(-0.5%) |
| Mar 2006 | - | $24.90 K(-1410.5%) | $108.10 K(+3.5%) |
| Dec 2005 | - | -$1900.00(-102.3%) | $104.40 K(-16.5%) |
| Sept 2005 | - | $83.80 K(+6346.2%) | $125.00 K(+158.3%) |
| June 2005 | $48.40 K(+0.6%) | $1300.00(-93.9%) | $48.40 K(+2.8%) |
| Mar 2005 | - | $21.20 K(+13.4%) | $47.10 K(+81.9%) |
| Dec 2004 | - | $18.70 K(+159.7%) | $25.90 K(+259.7%) |
| Sept 2004 | - | $7200.00 | $7200.00 |
| June 2004 | $48.10 K | - | - |
FAQ
- What is Bio-Path Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Bio-Path Holdings?
- What is Bio-Path Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Bio-Path Holdings?
- What is Bio-Path Holdings quarterly CFF year-on-year change?
- What is Bio-Path Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Bio-Path Holdings?
- What is Bio-Path Holdings TTM CFF year-on-year change?
What is Bio-Path Holdings annual cash flow from financing activities?
The current annual CFF of BPTH is $2.20 M
What is the all time high annual CFF for Bio-Path Holdings?
Bio-Path Holdings all-time high annual cash flow from financing activities is $27.78 M
What is Bio-Path Holdings quarterly cash flow from financing activities?
The current quarterly CFF of BPTH is -$16.00 K
What is the all time high quarterly CFF for Bio-Path Holdings?
Bio-Path Holdings all-time high quarterly cash flow from financing activities is $20.28 M
What is Bio-Path Holdings quarterly CFF year-on-year change?
Over the past year, BPTH quarterly cash flow from financing activities has changed by -$530.00 K (-103.11%)
What is Bio-Path Holdings TTM cash flow from financing activities?
The current TTM CFF of BPTH is $7.72 M
What is the all time high TTM CFF for Bio-Path Holdings?
Bio-Path Holdings all-time high TTM cash flow from financing activities is $27.78 M
What is Bio-Path Holdings TTM CFF year-on-year change?
Over the past year, BPTH TTM cash flow from financing activities has changed by +$5.51 M (+250.34%)